Phlebopress, capsules 300 mg 60 pcs
€1.00
Out of stock
(E-mail when Stock is available)
Semisynthetic bioflavonoid (rutin derivative) of benzopyran class, has P-vitamin activity, has venotonic, angioprotective, anti-inflammatory and anti-edema effect, reduces capillary permeability and fragility. Its pharmacodynamic properties are associated with the participation of troxerutin bioflavonoids in redox processes and hyaluronidase inhibition. Inhibiting hyaluronidase, troxerutin stabilizes hyaluronic acid of cell membranes and reduces their permeability.
It has antioxidant activity, as a result of which it prevents oxidation of ascorbic acid, adrenaline and lipids. In addition, it reduces capillary permeability and fragility, prevents damage to the basal membrane of endothelial cells when it is exposed to various factors. Troxerutin increases the density of the vascular wall, reduces the exudation of the liquid part of the plasma and diapedesis of blood cells.
Reduces exudative inflammation in the vascular wall, reducing platelet adhesion to its surface.
Inhibits aggregation and increases the degree of red blood cell deformation. Application of troxerutin is possible both in the initial and in the late stages of treatment of chronic venous insufficiency, it is possible to use as one of the components of complex treatment. Troxerutin reduces swelling and heaviness in the legs, reduces the intensity of pain and cramps, improves tissue trophism. Troxerutin relieves symptoms associated with hemorrhoids (pain, exudation, itching, bleeding). Due to influence on capillary permeability and resistance walls troxerutin helps to slow down progression of diabetic retinopathy.
The effect of troxerutin on the rheological properties of the blood prevents the development of retinal vascular microthrombosis.
Indications
The drug Phlebopress® capsules 300 mg is used in the treatment of the above diseases:
– chronic venous insufficiency;
– trophic disorders in chronic venous insufficiency and trophic ulcers;
– varicose veins;
– superficial thrombophlebitis, periphlebitis;
– postthrombotic syndrome;
– Post-traumatic edema and soft tissue hematomas;
– as a supportive treatment after sclerotherapy and/or removal of varicose veins of the lower extremities;
– hemorrhoids (to relieve symptoms);
– diabetic angiopathy, retinopathy.
Active ingredient
Troxerutin
Composition
Ingredients for 1 capsule: active substance: troxerutin – 300.00 mg
How to take, the dosage
Oral. Capsules should be swallowed whole, with meals, with plenty of water. At the initial stage of treatment, prescribe 1 capsule (300 mg) 3 times a day. The effect usually develops within 2 weeks. Then the treatment is continued in the same dose or reduced to the average therapeutic dose – 1 capsule 2 times a day (600 mg), or it is suspended (in this case the effect is maintained for at least 4 weeks).
If necessary, the dose may be increased after consultation with the doctor. The average course of treatment is 3-4 weeks. For maintenance therapy it is enough to take 1 capsule (300 mg) a day for 3 to 4 weeks. In diabetic retinopathy prescribes Flebopress® 2 capsules (single dose of 600 mg) 3 times a day (daily dose of 1.8 g). On average therapeutic course is 3-4 weeks. The need for longer treatment is determined after consultation with the physician and individually.
Contraindications
– Hypersensitivity to troxerutin and other components of the drug;
– Peptic ulcer, duodenal ulcer, chronic gastritis in the acute phase;
– Lactose intolerance or glucose-galactose malabsorption syndrome. – Lactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome;
– Pregnancy (I trimester);
– Breast-feeding;
– Childhood under 18 years (experience of use is limited).
Similarities
Troxerutin Vramed, Troxerutin Vetprom, Troxevasin, Troxerutin
Weight | 0.048 kg |
---|---|
Manufacturer | Ozon, Russia |
Medication form | capsules |
Brand | Ozon |
Related products
Buy Phlebopress, capsules 300 mg 60 pcs with delivery to USA, UK, Europe and over 120 other countries.